Literature DB >> 23955241

Neuroprotective activity of pDING in response to HIV-1 Tat.

Nune Darbinian1, Kamel Khalili, Shohreh Amini.   

Abstract

Although neurons are not productively infected with HIV-1, neuronal injury and death are frequently seen in the brains of AIDS patients with neurological and neurocognitive disorders. Evidently, viral proteins including Tat and cellular inflammatory factors released by activated and/or infected microglia, macrophages, and astrocytes contribute to neuronal cell death. Several studies have demonstrated that HIV-1 associated neuronal cell injury is mediated by dysregulation of signaling pathways that are controlled, in part, by a class of serine/threonine kinases. In this study, we demonstrate that pDING, a novel plant-derived phosphate binding protein has the capacity to reduce the severity of injury and death caused by HIV-1 and its neurotoxic Tat protein. We demonstrate that pDING, also called p27SJ/p38SJ, protects cells from the loss of neuronal processes induced by Tat and promotes neuronal outgrowth after Tat-mediated injury. Further, expression of pDING prevents Tat-induced oxidative stress and mitochondrial permeability. With its profound phosphatase activity, pDING controls the activity of several kinases including MAPK, Cdk5, and their downstream target protein, MEF2, which is implicated in neuronal cell protection. Our results show that expression of pDING in neuronal cells diminishes the level of hyperphosphorylated forms of Cdk5 and MEF2 caused by Tat and the other neurotoxic agents that are secreted by the HIV-1 infected cells. These observations suggest that pDING, through its phosphatase activity, has the ability to manipulate the state of phosphorylation and activity of several factors involved in neuronal cell health in response to HIV-1.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23955241      PMCID: PMC4204488          DOI: 10.1002/jcp.24392

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  43 in total

1.  Regulation of dendritic spine morphology and synaptic function by Shank and Homer.

Authors:  C Sala; V Piëch; N R Wilson; M Passafaro; G Liu; M Sheng
Journal:  Neuron       Date:  2001-07-19       Impact factor: 17.173

Review 2.  Mitogen-activated protein kinase p38 in HIV infection and associated brain injury.

Authors:  Kathryn E Medders; Marcus Kaul
Journal:  J Neuroimmune Pharmacol       Date:  2011-02-01       Impact factor: 4.147

3.  Ethanol inhibits development of dendrites and synapses in rat hippocampal pyramidal neuron cultures.

Authors:  P A Yanni; T A Lindsley
Journal:  Brain Res Dev Brain Res       Date:  2000-04-14

4.  Growth inhibition of malignant glioblastoma by DING protein.

Authors:  Markus J Bookland; Nune Darbinian; Michael Weaver; Shohreh Amini; Kamel Khalili
Journal:  J Neurooncol       Date:  2011-11-04       Impact factor: 4.130

5.  Neuronal activity-dependent cell survival mediated by transcription factor MEF2.

Authors:  Z Mao; A Bonni; F Xia; M Nadal-Vicens; M E Greenberg
Journal:  Science       Date:  1999-10-22       Impact factor: 47.728

Review 6.  Cdk5: a multifaceted kinase in neurodegenerative diseases.

Authors:  Zelda H Cheung; Nancy Y Ip
Journal:  Trends Cell Biol       Date:  2011-12-20       Impact factor: 20.808

Review 7.  MEF2: a calcium-dependent regulator of cell division, differentiation and death.

Authors:  Timothy A McKinsey; Chun Li Zhang; Eric N Olson
Journal:  Trends Biochem Sci       Date:  2002-01       Impact factor: 13.807

8.  Site-specific hyperphosphorylation of pRb in HIV-induced neurotoxicity.

Authors:  C Akay; K A Lindl; Y Wang; M G White; J Isaacman-Beck; D L Kolson; K L Jordan-Sciutto
Journal:  Mol Cell Neurosci       Date:  2011-04-12       Impact factor: 4.314

9.  Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis.

Authors:  Xiaoming Gong; Xiaoli Tang; Marcus Wiedmann; Xuemin Wang; Junmin Peng; Dong Zheng; Leslie A C Blair; John Marshall; Zixu Mao
Journal:  Neuron       Date:  2003-04-10       Impact factor: 17.173

10.  Association of VSNL1 with schizophrenia, frontal cortical function, and biological significance for its gene product as a modulator of cAMP levels and neuronal morphology.

Authors:  K H Braunewell; A D Dwary; F Richter; K Trappe; C Zhao; I Giegling; K Schönrath; D Rujescu
Journal:  Transl Psychiatry       Date:  2011-07-19       Impact factor: 6.222

View more
  10 in total

1.  Fetal Brain Injury Models of Fetal Alcohol Syndrome: Examination of Neuronal Morphologic Condition Using Sholl Assay.

Authors:  Nune Darbinian; Armine Darbinyan; Kamel Khalili; Shohreh Amini
Journal:  Methods Mol Biol       Date:  2021

2.  HIV Protease Inhibitors Alter Amyloid Precursor Protein Processing via β-Site Amyloid Precursor Protein Cleaving Enzyme-1 Translational Up-Regulation.

Authors:  Patrick J Gannon; Cagla Akay-Espinoza; Alan C Yee; Lisa A Briand; Michelle A Erickson; Benjamin B Gelman; Yan Gao; Norman J Haughey; M Christine Zink; Janice E Clements; Nicholas S Kim; Gabriel Van De Walle; Brigid K Jensen; Robert Vassar; R Christopher Pierce; Alexander J Gill; Dennis L Kolson; J Alan Diehl; Joseph L Mankowski; Kelly L Jordan-Sciutto
Journal:  Am J Pathol       Date:  2017-01       Impact factor: 4.307

3.  HIV-1 Tat alters neuronal autophagy by modulating autophagosome fusion to the lysosome: implications for HIV-associated neurocognitive disorders.

Authors:  Jerel Fields; Wilmar Dumaop; Simona Eleuteri; Simona Elueteri; Sofia Campos; Elisabeth Serger; Margarita Trejo; Kori Kosberg; Anthony Adame; Brian Spencer; Edward Rockenstein; Johnny J He; Eliezer Masliah
Journal:  J Neurosci       Date:  2015-02-04       Impact factor: 6.167

4.  Creatine protects against mitochondrial dysfunction associated with HIV-1 Tat-induced neuronal injury.

Authors:  Patrick R Stevens; Jeremy W Gawryluk; Liang Hui; Xuesong Chen; Jonathan D Geiger
Journal:  Curr HIV Res       Date:  2014       Impact factor: 1.581

Review 5.  Targeting the Brain Reservoirs: Toward an HIV Cure.

Authors:  Céline Marban; Faezeh Forouzanfar; Amina Ait-Ammar; Faiza Fahmi; Hala El Mekdad; Fadoua Daouad; Olivier Rohr; Christian Schwartz
Journal:  Front Immunol       Date:  2016-09-30       Impact factor: 7.561

6.  HIV-1 and HIV-1-Tat Induce Mitochondrial DNA Damage in Human Neurons.

Authors:  Nune Darbinian; Armine Darbinyan; Nana Merabova; Michael E Selzer; Shohreh Amini
Journal:  J HIV AIDS       Date:  2020-08-31

7.  Gestational Age Variation in Human Placental Drug Transporters.

Authors:  Laura Goetzl; Nune Darbinian; Nana Merabova; Lindsay C Devane; Sammanda Ramamoorthy
Journal:  Front Pharmacol       Date:  2022-04-06       Impact factor: 5.988

Review 8.  Hypericum Genus as a Natural Source for Biologically Active Compounds.

Authors:  Gonçalo Infante Caldeira; Luís Pleno Gouveia; Rita Serrano; Olga Duarte Silva
Journal:  Plants (Basel)       Date:  2022-09-26

Review 9.  Viral and cellular factors underlying neuropathogenesis in HIV associated neurocognitive disorders (HAND).

Authors:  Vasudev R Rao; Arthur P Ruiz; Vinayaka R Prasad
Journal:  AIDS Res Ther       Date:  2014-05-19       Impact factor: 2.250

10.  DING Protein Inhibits Transcription of HIV-1 Gene through Suppression of Phosphorylation of NF-κB p65.

Authors:  Nune Darbinian; Armine Darbinyan; Nana Merabova; Rebeccah Gomberg; Erik Chabriere; Malgorzata Simm; Michael E Selzer; Shohreh Amini
Journal:  J HIV AIDS       Date:  2020-08-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.